BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 16616289)

  • 1. Promoter switching allows simultaneous transcription of LANA and K14/vGPCR of Kaposi's sarcoma-associated herpesvirus.
    Staudt MR; Dittmer DP
    Virology; 2006 Jun; 350(1):192-205. PubMed ID: 16616289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential regulation of the overlapping Kaposi's sarcoma-associated herpesvirus vGCR (orf74) and LANA (orf73) promoters.
    Jeong J; Papin J; Dittmer D
    J Virol; 2001 Feb; 75(4):1798-807. PubMed ID: 11160678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accumulation of heterochromatin components on the terminal repeat sequence of Kaposi's sarcoma-associated herpesvirus mediated by the latency-associated nuclear antigen.
    Sakakibara S; Ueda K; Nishimura K; Do E; Ohsaki E; Okuno T; Yamanishi K
    J Virol; 2004 Jul; 78(14):7299-310. PubMed ID: 15220403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RBP-J (CSL) is essential for activation of the K14/vGPCR promoter of Kaposi's sarcoma-associated herpesvirus by the lytic switch protein RTA.
    Liang Y; Ganem D
    J Virol; 2004 Jul; 78(13):6818-26. PubMed ID: 15194757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct interactions of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 ORF50/Rta protein with the cellular protein octamer-1 and DNA are critical for specifying transactivation of a delayed-early promoter and stimulating viral reactivation.
    Carroll KD; Khadim F; Spadavecchia S; Palmeri D; Lukac DM
    J Virol; 2007 Aug; 81(16):8451-67. PubMed ID: 17537858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA binding by Kaposi's sarcoma-associated herpesvirus lytic switch protein is necessary for transcriptional activation of two viral delayed early promoters.
    Lukac DM; Garibyan L; Kirshner JR; Palmeri D; Ganem D
    J Virol; 2001 Aug; 75(15):6786-99. PubMed ID: 11435557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen by the lytic transactivator RTA: a novel mechanism for establishment of latency.
    Lan K; Kuppers DA; Verma SC; Sharma N; Murakami M; Robertson ES
    J Virol; 2005 Jun; 79(12):7453-65. PubMed ID: 15919901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen modulates K1 expression through its cis-acting elements within the terminal repeats.
    Verma SC; Lan K; Choudhuri T; Robertson ES
    J Virol; 2006 Apr; 80(7):3445-58. PubMed ID: 16537612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lytic but not latent infection by Kaposi's sarcoma-associated herpesvirus requires host CSL protein, the mediator of Notch signaling.
    Liang Y; Ganem D
    Proc Natl Acad Sci U S A; 2003 Jul; 100(14):8490-5. PubMed ID: 12832621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kaposi's sarcoma-associated herpesvirus (KSHV) Rta and cellular HMGB1 proteins synergistically transactivate the KSHV ORF50 promoter.
    Harrison SM; Whitehouse A
    FEBS Lett; 2008 Sep; 582(20):3080-4. PubMed ID: 18692049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kaposi's Sarcoma-associated herpesvirus lytic switch protein stimulates DNA binding of RBP-Jk/CSL to activate the Notch pathway.
    Carroll KD; Bu W; Palmeri D; Spadavecchia S; Lynch SJ; Marras SA; Tyagi S; Lukac DM
    J Virol; 2006 Oct; 80(19):9697-709. PubMed ID: 16973574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of Kaposi's sarcoma-associated herpesvirus (KSHV) K1 promoter activation by Rta.
    Bowser BS; Morris S; Song MJ; Sun R; Damania B
    Virology; 2006 May; 348(2):309-27. PubMed ID: 16546233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of the Kaposi's sarcoma-associated herpesvirus major latency locus by the lytic switch protein RTA (ORF50).
    Matsumura S; Fujita Y; Gomez E; Tanese N; Wilson AC
    J Virol; 2005 Jul; 79(13):8493-505. PubMed ID: 15956592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen inhibits lytic replication by targeting Rta: a potential mechanism for virus-mediated control of latency.
    Lan K; Kuppers DA; Verma SC; Robertson ES
    J Virol; 2004 Jun; 78(12):6585-94. PubMed ID: 15163750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kaposi's sarcoma-associated herpesvirus reactivation is regulated by interaction of latency-associated nuclear antigen with recombination signal sequence-binding protein Jkappa, the major downstream effector of the Notch signaling pathway.
    Lan K; Kuppers DA; Robertson ES
    J Virol; 2005 Mar; 79(6):3468-78. PubMed ID: 15731241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular-activated Notch1 can reactivate Kaposi's sarcoma-associated herpesvirus from latency.
    Lan K; Murakami M; Choudhuri T; Kuppers DA; Robertson ES
    Virology; 2006 Aug; 351(2):393-403. PubMed ID: 16701788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activated Nrf2 Interacts with Kaposi's Sarcoma-Associated Herpesvirus Latency Protein LANA-1 and Host Protein KAP1 To Mediate Global Lytic Gene Repression.
    Gjyshi O; Roy A; Dutta S; Veettil MV; Dutta D; Chandran B
    J Virol; 2015 Aug; 89(15):7874-92. PubMed ID: 25995248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the NEDD8-Activating Enzyme Inhibitor MLN4924 on Lytic Reactivation of Kaposi's Sarcoma-Associated Herpesvirus.
    Chang PJ; Chen LW; Chen LY; Hung CH; Shih YJ; Wang SS
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28701396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amplification of the Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 lytic origin of DNA replication is dependent upon a cis-acting AT-rich region and an ORF50 response element and the trans-acting factors ORF50 (K-Rta) and K8 (K-bZIP).
    AuCoin DP; Colletti KS; Cei SA; Papousková I; Tarrant M; Pari GS
    Virology; 2004 Jan; 318(2):542-55. PubMed ID: 14972523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kaposi's sarcoma-associated herpesvirus latent protein LANA interacts with HIF-1 alpha to upregulate RTA expression during hypoxia: Latency control under low oxygen conditions.
    Cai Q; Lan K; Verma SC; Si H; Lin D; Robertson ES
    J Virol; 2006 Aug; 80(16):7965-75. PubMed ID: 16873253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.